TARAMASSO, LUCIA
TARAMASSO, LUCIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
2018 M. Fabbiani, R. Gagliardini, N. Ciccarelli, E. Quiros Roldan, A. Latini, G. D'Ettorre, A. Antinori, A. Castagna, G. Orofino, D. Francisci, P. Chinello, G. Madeddu, P. Grima, S. Rusconi, B. Del Pin, F. Lombardi, A. D'Avino, E. Focà, M. Colafigli, R. Cauda, S. Di Giambenedetto, A. De Luca, L. Taramasso
Aumento del peso nelle persone che vivono con infezione da HIV: ritorno al benessere o effetto indesiderato della terapia antiretrovirale? = Weight gain in people living with HIV infection : return to health or adverse event of antiretroviral therapy?
2020 L. Taramasso, G. Bozzi, A. Muscatello, A. Bandera, A. Gori
Bedaquiline : a new hope for shorter and better anti-tuberculosis regimens
2018 N. Riccardi, F. Del Puente, F. Magne, L. Taramasso, A. Di Biagio
Bloodstream infections in HIV-infected patients
2016 L. Taramasso, P. Tatarelli, A. Di Biagio
Bloodstream infections in patients living with HIV in the modern cART era
2019 L. Taramasso, F. Liggieri, G. Cenderello, F. Bovis, B. Giannini, A. Mesini, M. Giacomini, G. Cassola, C. Viscoli, A. Di Biagio
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?
2017 L. Taramasso, F. Liggieri, G. Cenderello, F. Bovis, A. Mesini, B. Giannini, M. Giacomini, G. Cassola, C. Viscoli, A. Di Biagio
Case report : management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir
2012 M.K. Mikulska, L. Taramasso, D. Giacobbe, P. Caligiuri, B. Bruzzone, A. Di Biagio, C. Viscoli
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?
2018 D. Fenoglio, C. Dentone, A. Signori, A. Di Biagio, A. Parodi, F. Kalli, G. Nasi, M. Curto, G. Cenderello, P. De Leo, V. Bartolacci, G. Orofino, L.A. Nicolini, L. Taramasso, E. Fiorillo, V. Orrù, P. Traverso, B. Bruzzone, F. Ivaldi, E. Mantia, M. Guerra, S. Negrini, M. Giacomini, S. Bhagani, G. Filaci
Chemotherapy Mass Campaigns and Migratory Flows : An Unexpected Connection
2016 G. Cenderello, L. Taramasso, N. Riccardi, A. Di Biagio, G. Cassola, A. De Maria
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection : Much Ado About Nothing?
2017 L. Taramasso, E. Ricci, B. Celesia, P. Bonfanti, T. Quirino, N. Squillace, L.A. Nicolini, P. Maggi, C. Martinelli, G. De Socio, A. Di Biagio
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells
2017 F. Marras, A. Casabianca, F. Bozzano, M.L. Ascierto, C. Orlandi, A. Di Biagio, E. Pontali, C. Dentone, G. Orofino, L. Nicolini, L. Taramasso, M. Magnani, F.M. Marincola, E. Wang, L. Moretta, A. De Maria
Duration of isolation and precautions in immunocompromised patients with COVID-19
2021 L. Taramasso, C. Sepulcri, M. Mikulska, L. Magnasco, A. Lai, B. Bruzzone, C. Dentone, M. Bassetti
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer
2020 A. Lombardi, G. Bozzi, D. Mangioni, A. Muscatello, A.M. Peri, L. Taramasso, R. Ungaro, A. Bandera, A. Gori
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo
2013 F. Bisio, G. Masini, E. Vacca, A. Calzi, F. Cardinale, B. Bruzzone, P. Bruzzi, C. Viscoli, K. Kento Mwana, J. Nkouendolo, J. Moutou, H. Banguissa, L. Nicolini, E. Schenone, E. Repetto, C. Montaldo, S. Ferrando, E. Righi, C. Dentone, S. Farinella, F. Vitale, M. Izzo, A. Mularoni, M. Mikulska, L. Di Stefano, E. Malfatto, C. Bernardini, F. Ginocchio, G. Secondo, E. Delfino, E. Nicco, R. Prinapori, A. Parisini, L. De Hoffer, A. Mesini, S. Grignolo, L. Taramasso, D. Giacobbe, F. Artom, S. Dini, A. Beltrame, S. Ratto, F. Mbongou, L. Miguel, A. Nzagou, P. Mayembo, D. Ibata, A. Ventura, N. Nigro, C. Andrei, G. Icardi
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status
2015 L.A. Nicolini, L. Taramasso, I. Schiavetti, E.G. Giannini, A. Beltrame, M. Feasi, G. Cassola, A. Grasso, V. Bartolacci, L. Sticchi, A. Picciotto, C. Viscoli
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy
2011 M. Bassetti, L. Taramasso, E. Nicco, M. Molinari, M. Mussap, C. Viscoli
Factors associated with hospital admission for COVID-19 in HIV patients
2020 A. Di Biagio, E. Ricci, L. Calza, N. Squillace, B. Menzaghi, S. Rusconi, G. Orofino, O. Bargiacchi, C. Molteni, L. Valsecchi, G. Cenderello, S. Ferrara, A. Saracino, P. Maggi, K. Falasca, L. Taramasso, P. Bonfanti
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison
2018 L. Taramasso, A. Di Biagio, F. Maggiolo, A. Tavelli, S. Lo Caputo, S. Bonora, M. Zaccarelli, P. Caramello, A. Costantini, C. Viscoli, A. d'Arminio Monforte, A. Cozzi-Lepri
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions : a regional simulation
2019 G. Cenderello, L. Taramasso, D. Marra, P. Orcamo, A. Pasa, A. Di Biagio
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment
2018 L. Taramasso, L. Montanari, A. Di Biagio